Furthermore, nestin targeting via small interfering RNA (siRNA) has a tumor inhibitory effect in vivo via the inhibition of tumor angiogenesis in a mouse model of pancreatic cancer [200], suggesting that nestin could be a potential therapeutic target of tumor angiogenesis. The gene discussed is NES; the disease is familial pancreatic carcinoma.